Understanding Ehlers-Danlos Syndrome: A Claims-Based Analysis of Healthcare Cost Patterns.
Ehlers-Danlos Syndrome drives high healthcare costs primarily in the first year after diagnosis, suggesting early intervention opportunities.
Background: Ehlers-Danlos Syndrome (EDS) is a rare connective tissue disorder associated with substantial clinical complexity and healthcare utilization. Two-part models showed that the likelihood of incurring any cost was significantly higher in Year 1 (β = 4.15, P < .001) but not in Year 2 (β = -0.03, P = .845).
What the study was
- Study design
- Cohort study
- Population
- patients
- Sample size
- 4765
- Category
- Other
- Maturity
- Exploratory
- Journal
- Journal of health economics and outcomes research
Why it surfaced
Score 6/10 [PROMISING_PRELIMINARY]: Cohort study (Journal Article) matched 'Rare diseases with high unmet need'. Components — novelty:1/3, relevance:2/3, design:1/2, population:2/2. Confidence: high. Conservative scoring applied per v1.3 rubric.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.